TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ALB

Albemarle Corp

Basic Materials · Specialty Chemicals

104.60$ -0.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios ALB
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Valuation
6.8 16.6 14.6 10.3 11.4 16.4 16.8 17.6 30.0 16.0 24.4 17.5 10.6 18.8 16.3 12.0 17.9 12.9 35.7 18.7 15.1 262.0 12.2 14.6 41.9 220.3 9.5 10.8 – –
1.2 1.6 1.5 1.1 1.3 1.2 1.2 1.1 1.1 0.9 1.5 1.7 0.8 1.7 2.2 1.6 2.2 2.2 1.9 2.2 3.6 4.7 2.5 2.2 5.0 8.2 3.5 1.8 1.9 3.2
2.1 2.6 2.7 1.9 2.1 1.9 2.2 2.0 2.3 2.0 3.4 3.1 1.9 2.8 3.6 3.0 3.0 3.3 3.5 1.9 2.6 3.9 2.4 2.0 3.7 4.8 3.2 1.8 1.0 1.7
1.2 1.6 1.5 1.0 1.3 1.3 1.4 1.3 1.7 1.2 1.7 2.0 1.1 1.9 2.3 1.7 2.3 2.5 2.1 3.5 3.7 4.9 2.8 2.8 5.9 8.8 3.7 2.1 2.3 3.5
6.4 6.8 6.1 4.3 5.5 7.1 7.5 8.2 13.7 8.4 10.7 10.9 6.9 12.4 10.6 7.3 9.5 8.2 12.1 13.5 13.4 18.4 10.4 11.3 24.5 53.6 7.5 7.7 – 32.5
– 98.2 20.5 10.5 11.2 11.9 11.6 11.6 12.3 18.6 12.6 27.9 9.6 13.0 20.1 18.1 26.8 19.3 12.4 47.0 18.2 – – – – – 39.5 – – 24.0
-5.8% 1.0% 4.9% 9.5% 8.9% 8.4% 8.7% 8.6% 8.1% 5.4% 7.9% 3.6% 10.5% 7.7% 5.0% 5.5% 3.7% 5.2% 8.0% 2.1% 5.5% -0.1% -1.8% -1.7% -0.3% -2.2% 2.5% -4.9% -9.8% 4.2%
Margins
36.8% 39.8% 40.9% 40.2% 29.6% 23.5% 23.1% 21.5% 20.9% 20.2% 23.3% 26.6% 24.6% 24.1% 31.6% 34.1% 36.1% 36.0% 31.5% 30.4% 36.3% 36.6% 36.2% 35.1% 31.8% 30.3% 42.2% 12.5% 1.1% 13.1%
10.9% 14.6% 15.3% 14.8% 16.4% 10.4% 10.2% 8.4% 8.4% 7.8% 11.3% 13.5% 11.6% 10.5% 17.9% 20.5% 20.2% 25.7% 13.4% 16.7% 19.0% 20.3% 21.5% 19.1% 16.8% 16.0% 34.2% 2.5% -11.8% 1.8%
18.3% 9.6% 10.3% 10.5% 11.1% 7.2% 7.2% 6.5% 3.6% 5.5% 6.0% 9.8% 7.9% 8.9% 13.4% 13.7% 12.4% 17.3% 5.5% 11.8% 24.0% 1.8% 20.6% 14.9% 12.0% 3.7% 36.7% 16.4% -21.9% -9.9%
-7.3% 1.6% 7.4% 10.3% 11.2% 10.0% 10.6% 9.8% 8.8% 4.7% 11.7% 6.2% 8.8% 12.9% 10.8% 9.1% 8.3% 11.6% 15.6% 4.7% 20.0% -0.4% -4.6% -3.7% -1.6% -18.3% 8.8% -8.6% -18.5% 13.5%
Returns
30.9% 15.5% 18.8% 18.1% 18.2% 11.5% 12.8% 11.3% 7.7% 12.3% 13.9% 18.0% 18.2% 14.8% 22.3% 24.6% 17.0% 25.4% 9.8% 10.3% 17.0% 1.5% 19.3% 13.6% 8.8% 2.2% 33.7% 16.7% -11.8% -5.4%
18.4% 9.0% 9.0% 9.3% 10.4% 6.0% 6.1% 5.2% 2.2% 4.5% 5.7% 8.1% 6.8% 6.4% 10.3% 12.2% 9.1% 11.5% 2.6% 3.5% 7.9% 0.7% 9.1% 5.4% 3.6% 1.1% 17.4% 8.6% -7.1% -3.1%
Balance Sheet & Debt
-6.8 -34 -21 -48 79 140 143 193 898 775 583 593 679 504 331 294 222 602 444 3,603 100 700 1,150 2,401 2,825 1,955 1,718 3,277 2,324 1,576
0.0 -0.2 -0.1 -0.2 0.4 0.8 0.8 1.1 4.8 2.5 1.5 1.4 1.7 1.6 0.6 0.4 0.4 0.8 1.0 4.9 0.1 0.9 1.2 2.7 3.7 3.6 0.5 1.2 – 2.8
59.7% 58.2% 48.2% 51.4% 56.9% 52.5% 47.8% 45.9% 29.1% 36.5% 40.6% 45.2% 37.5% 43.5% 46.2% 49.7% 53.3% 45.4% 26.0% 33.8% 46.5% 47.4% 47.3% 39.9% 40.8% 51.3% 51.6% 51.5% 60.0% 58.2%
0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.4 1.3 0.9 0.7 0.6 0.9 0.7 0.6 0.5 0.4 0.7 2.2 1.2 0.6 0.5 0.5 0.8 0.8 0.4 0.4 0.4 0.4 0.3
Per Share
1.32 0.72 0.81 0.93 1.09 0.73 0.85 0.85 0.64 1.20 1.47 2.36 2.10 1.94 3.43 4.28 3.47 4.90 1.69 3.00 5.68 0.49 6.34 5.02 3.52 1.06 22.84 13.36 -10.04 -4.34
7.25 7.47 7.87 8.90 9.84 10.13 11.68 13.17 17.80 22.07 24.38 24.03 26.66 21.79 25.63 31.35 28.03 28.39 30.92 25.34 23.64 27.34 30.83 33.76 29.29 28.56 62.14 81.66 45.76 43.69
4.29 4.66 4.33 5.16 6.00 6.38 6.60 7.55 8.36 9.74 10.58 13.15 11.52 13.10 15.36 17.39 20.40 19.30 17.19 29.17 33.51 32.70 32.76 36.98 39.96 48.27 67.77 79.92 84.77 81.00
-0.53 0.12 0.58 0.91 1.10 1.01 1.23 1.29 1.57 1.03 2.85 1.48 2.33 2.80 2.78 2.84 2.31 3.29 4.83 1.19 4.74 -0.12 -1.41 -1.25 -0.48 -5.23 5.49 -7.03 -8.45 5.88

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?